APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Live Attenuated Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Live Attenuated Rotavirus Vaccine Industry Growth and Trends Forecast to 2032

Report ID 173817570128 December 202570 pages

Choose your research edition.

Industry ResearchLive Attenuated Rotavirus Vaccine Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Live Attenuated Rotavirus Vaccine Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Live Attenuated Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Live Attenuated Rotavirus Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Live Attenuated Rotavirus Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Live Attenuated Rotavirus Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Live Attenuated Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Live Attenuated Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Live Attenuated Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Live Attenuated Rotavirus Vaccine include Bharat Biotech, GSK, Lanzhou Biological Products Research Institute and Merck Sharp & Dohme, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Live Attenuated Rotavirus Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Live Attenuated Rotavirus Vaccine market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Live Attenuated Rotavirus Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Live Attenuated Rotavirus Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Live Attenuated Rotavirus Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Live Attenuated Rotavirus Vaccine Market by Company

Bharat Biotech

GSK

Lanzhou Biological Products Research Institute

Merck Sharp & Dohme

Live Attenuated Rotavirus Vaccine Segment by Type

Monovalent Vaccines

Combination Vaccines

Live Attenuated Rotavirus Vaccine Segment by Application

Hospitals and Clinics

Vaccination Sites

Live Attenuated Rotavirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Attenuated Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Live Attenuated Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Attenuated Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Live Attenuated Rotavirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Live Attenuated Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Monovalent Vaccines Table 2. Major Company of Combination Vaccines Table 3. Global Live Attenuated Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 5. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Live Attenuated Rotavirus Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (Units) Table 10. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Live Attenuated Rotavirus Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 15. North America Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 17. Europe Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 19. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 21. Latin America Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 23. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Live Attenuated Rotavirus Vaccine Industry Trends Table 25. Live Attenuated Rotavirus Vaccine Industry Drivers Table 26. Live Attenuated Rotavirus Vaccine Industry Opportunities and Challenges Table 27. Live Attenuated Rotavirus Vaccine Industry Restraints Table 28. Global Live Attenuated Rotavirus Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Live Attenuated Rotavirus Vaccine Sales by Company (2021-2026) & (Units) Table 31. Global Live Attenuated Rotavirus Vaccine Sales Share by Company (2021-2026) Table 32. Global Live Attenuated Rotavirus Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Live Attenuated Rotavirus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Live Attenuated Rotavirus Vaccine Major Company Production Sites and Headquarters Table 35. Global Live Attenuated Rotavirus Vaccine Company, Product Type & Application Table 36. Global Live Attenuated Rotavirus Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Live Attenuated Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Live Attenuated Rotavirus Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026) & (Units) Table 41. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Live Attenuated Rotavirus Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Live Attenuated Rotavirus Vaccine Sales by Region (2027-2032) & (Units) Table 46. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Live Attenuated Rotavirus Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Live Attenuated Rotavirus Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Live Attenuated Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 52. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Live Attenuated Rotavirus Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (Units) Table 57. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Live Attenuated Rotavirus Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 62. North America Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 64. Europe Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 66. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 68. Latin America Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 70. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Bharat Biotech Company Information Table 72. Bharat Biotech Business Overview Table 73. Bharat Biotech Live Attenuated Rotavirus Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bharat Biotech Live Attenuated Rotavirus Vaccine Product Portfolio Table 75. Bharat Biotech Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Live Attenuated Rotavirus Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. GSK Live Attenuated Rotavirus Vaccine Product Portfolio Table 80. GSK Recent Development Table 81. Lanzhou Biological Products Research Institute Company Information Table 82. Lanzhou Biological Products Research Institute Business Overview Table 83. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Portfolio Table 85. Lanzhou Biological Products Research Institute Recent Development Table 86. Merck Sharp & Dohme Company Information Table 87. Merck Sharp & Dohme Business Overview Table 88. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product Portfolio Table 90. Merck Sharp & Dohme Recent Development Table 91. North America Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 92. North America Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (Units) Table 93. North America Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 94. North America Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 95. North America Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 96. North America Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Live Attenuated Rotavirus Vaccine Market Share by Country (2021-2026) Table 99. North America Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Live Attenuated Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 101. Europe Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 102. Europe Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (Units) Table 103. Europe Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 104. Europe Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 105. Europe Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Live Attenuated Rotavirus Vaccine Market Share by Country (2021-2026) Table 109. Europe Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Live Attenuated Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (Units) Table 113. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 115. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Live Attenuated Rotavirus Vaccine Market Share by Country (2021-2026) Table 119. Asia-Pacific Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Live Attenuated Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 121. Latin America Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 122. Latin America Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (Units) Table 123. Latin America Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 124. Latin America Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 125. Latin America Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Live Attenuated Rotavirus Vaccine Market Share by Country (2021-2026) Table 129. Latin America Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Live Attenuated Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (Units) Table 133. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 135. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Share by Country (2021-2026) Table 139. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Live Attenuated Rotavirus Vaccine Distributors List Table 144. Live Attenuated Rotavirus Vaccine Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Live Attenuated Rotavirus Vaccine Image Figure 2. Global Live Attenuated Rotavirus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Live Attenuated Rotavirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Live Attenuated Rotavirus Vaccine Sales (2021-2032) & (Units) Figure 5. Monovalent Vaccines Image Figure 6. Global Monovalent Vaccines Sales YoY Growth (2021-2032) & (Units) Figure 7. Combination Vaccines Image Figure 8. Global Combination Vaccines Sales YoY Growth (2021-2032) & (Units) Figure 9. Global Live Attenuated Rotavirus Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Live Attenuated Rotavirus Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Live Attenuated Rotavirus Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals and Clinics Image Figure 24. Global Hospitals and Clinics Sales YoY Growth (2021-2032) & (Units) Figure 25. Vaccination Sites Image Figure 26. Global Vaccination Sites Sales YoY Growth (2021-2032) & (Units) Figure 27. Global Live Attenuated Rotavirus Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Live Attenuated Rotavirus Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Live Attenuated Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 40. North America Live Attenuated Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Live Attenuated Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Live Attenuated Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 44. Europe Live Attenuated Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Live Attenuated Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 48. Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Live Attenuated Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Live Attenuated Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 52. Latin America Live Attenuated Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Live Attenuated Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 56. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Live Attenuated Rotavirus Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Live Attenuated Rotavirus Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccines
  • Combination Vaccines
Applications
  • Hospitals and Clinics
  • Vaccination Sites
Companies covered
  • Bharat Biotech
  • GSK
  • Lanzhou Biological Products Research Institute
  • Merck Sharp & Dohme

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Live Attenuated Rotavirus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Live Attenuated Rotavirus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Live Attenuated Rotavirus Vaccine Market by Type
  6. 1.3.1 Monovalent Vaccines
  7. 1.3.2 Combination Vaccines
  8. 1.4 Global Live Attenuated Rotavirus Vaccine Market Size by Type
  9. 1.4.1 Global Live Attenuated Rotavirus Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Live Attenuated Rotavirus Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Live Attenuated Rotavirus Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Live Attenuated Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Live Attenuated Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Live Attenuated Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Live Attenuated Rotavirus Vaccine Industry Trends
  2. 2.2 Live Attenuated Rotavirus Vaccine Industry Drivers
  3. 2.3 Live Attenuated Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Live Attenuated Rotavirus Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Live Attenuated Rotavirus Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Live Attenuated Rotavirus Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Live Attenuated Rotavirus Vaccine Price (2021-2026)
  4. 3.4 Global Live Attenuated Rotavirus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Live Attenuated Rotavirus Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Live Attenuated Rotavirus Vaccine Company, Product Type & Application
  7. 3.7 Global Live Attenuated Rotavirus Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Live Attenuated Rotavirus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Live Attenuated Rotavirus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Live Attenuated Rotavirus Vaccine Tier 1, Tier 2, and Tier 3
4 Live Attenuated Rotavirus Vaccine Regional Status and Outlook
  1. 4.1 Global Live Attenuated Rotavirus Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Live Attenuated Rotavirus Vaccine Historic Market Size by Region
  3. 4.2.1 Global Live Attenuated Rotavirus Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Live Attenuated Rotavirus Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Live Attenuated Rotavirus Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Live Attenuated Rotavirus Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Live Attenuated Rotavirus Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Live Attenuated Rotavirus Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Live Attenuated Rotavirus Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Live Attenuated Rotavirus Vaccine by Application
  1. 5.1 Live Attenuated Rotavirus Vaccine Market by Application
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Vaccination Sites
  4. 5.2 Global Live Attenuated Rotavirus Vaccine Market Size by Application
  5. 5.2.1 Global Live Attenuated Rotavirus Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Live Attenuated Rotavirus Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Live Attenuated Rotavirus Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Live Attenuated Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Live Attenuated Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Live Attenuated Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bharat Biotech
  2. 6.1.1 Bharat Biotech Company Information
  3. 6.1.2 Bharat Biotech Business Overview
  4. 6.1.3 Bharat Biotech Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bharat Biotech Live Attenuated Rotavirus Vaccine Product Portfolio
  6. 6.1.5 Bharat Biotech Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Live Attenuated Rotavirus Vaccine Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Lanzhou Biological Products Research Institute
  14. 6.3.1 Lanzhou Biological Products Research Institute Company Information
  15. 6.3.2 Lanzhou Biological Products Research Institute Business Overview
  16. 6.3.3 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Portfolio
  18. 6.3.5 Lanzhou Biological Products Research Institute Recent Developments
  19. 6.4 Merck Sharp & Dohme
  20. 6.4.1 Merck Sharp & Dohme Company Information
  21. 6.4.2 Merck Sharp & Dohme Business Overview
  22. 6.4.3 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product Portfolio
  24. 6.4.5 Merck Sharp & Dohme Recent Developments
7 North America by Country
  1. 7.1 North America Live Attenuated Rotavirus Vaccine Sales by Country
  2. 7.1.1 North America Live Attenuated Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Live Attenuated Rotavirus Vaccine Market Size by Country
  6. 7.2.1 North America Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Live Attenuated Rotavirus Vaccine Sales by Country
  2. 8.1.1 Europe Live Attenuated Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Live Attenuated Rotavirus Vaccine Market Size by Country
  6. 8.2.1 Europe Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Live Attenuated Rotavirus Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Live Attenuated Rotavirus Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Live Attenuated Rotavirus Vaccine Sales by Country
  2. 10.1.1 South America Live Attenuated Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Live Attenuated Rotavirus Vaccine Market Size by Country
  6. 10.2.1 South America Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Live Attenuated Rotavirus Vaccine Value Chain Analysis
  2. 12.1.1 Live Attenuated Rotavirus Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Live Attenuated Rotavirus Vaccine Production Mode & Process
  7. 12.2 Live Attenuated Rotavirus Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Live Attenuated Rotavirus Vaccine Distributors
  10. 12.2.3 Live Attenuated Rotavirus Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst